Innovative approaches for cocaine pharmacotherapy using fMRI: the case of varenicline.
- Conditions
- cocaine addiction
- Registration Number
- NL-OMON22626
- Lead Sponsor
- AMC Amsterdam, The Netherlands
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
1. Male, age 18-60 years;
2. Current DSM-IV diagnosis of cocaine dependence, but recently detoxified and abstinent;
Exclusion Criteria
1. Currently dependent on any substance other than cocaine or nicotine;
2. History of depression that could be defined as even a single episode or recurrent episodes of depression, or depression necessitating hospitalization, or history of suicide attempt (see fotenote1);
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Does varenicline reduce craving to cocaine and/or impulsivity in human cocaine users?
- Secondary Outcome Measures
Name Time Method